Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05207709
Title Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype (HARMONIA)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group

Her2-receptor negative breast cancer


Letrozole + Ribociclib

Fulvestrant + Palbociclib

Letrozole + Palbociclib

Fulvestrant + Ribociclib


Age Groups: senior | adult
Covered Countries ESP

No variant requirements are available.